ATE160486T1 - Nahrungsmittelzusammensetzung - Google Patents
NahrungsmittelzusammensetzungInfo
- Publication number
- ATE160486T1 ATE160486T1 AT91810629T AT91810629T ATE160486T1 AT E160486 T1 ATE160486 T1 AT E160486T1 AT 91810629 T AT91810629 T AT 91810629T AT 91810629 T AT91810629 T AT 91810629T AT E160486 T1 ATE160486 T1 AT E160486T1
- Authority
- AT
- Austria
- Prior art keywords
- food composition
- mgf
- humans
- beta
- animals
- Prior art date
Links
- 235000013305 food Nutrition 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 210000003022 colostrum Anatomy 0.000 abstract 1
- 235000021277 colostrum Nutrition 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/54—Proteins
- A23V2250/542—Animal Protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Grain Derivatives (AREA)
- Dairy Products (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Seeds, Soups, And Other Foods (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP91810629A EP0527283B1 (de) | 1991-08-12 | 1991-08-12 | Nahrungsmittelzusammensetzung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE160486T1 true ATE160486T1 (de) | 1997-12-15 |
Family
ID=8208868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91810629T ATE160486T1 (de) | 1991-08-12 | 1991-08-12 | Nahrungsmittelzusammensetzung |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5461033A (de) |
| EP (1) | EP0527283B1 (de) |
| JP (1) | JP2784297B2 (de) |
| KR (1) | KR930003844A (de) |
| AT (1) | ATE160486T1 (de) |
| AU (1) | AU658900B2 (de) |
| BR (1) | BR9203106A (de) |
| DE (1) | DE69128283T2 (de) |
| DK (1) | DK0527283T3 (de) |
| ES (1) | ES2110986T3 (de) |
| GR (1) | GR3025647T3 (de) |
| PT (1) | PT100766B (de) |
Families Citing this family (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPN271295A0 (en) * | 1995-05-02 | 1995-05-25 | Gropep Pty Ltd | Method of treatment |
| FR2684383B1 (fr) * | 1991-12-02 | 1994-03-11 | Institut Nal Sante Recherc Medic | Cytokine agoniste de l'ifn-gamma. |
| WO1994009651A1 (en) * | 1992-10-30 | 1994-05-11 | Cancer Research Fund Of Contra Costa | Anti-diarrheic product and method of treating rotavirus-associated infection |
| EP0686396B1 (de) * | 1994-02-25 | 2000-09-27 | Societe Des Produits Nestle S.A. | Micellares Kasein enthaltende enterale Zusammensetzung |
| AUPM534794A0 (en) * | 1994-04-28 | 1994-05-19 | Gropep Pty Ltd | Modified milk growth factor |
| AU702002B2 (en) * | 1994-04-28 | 1999-02-11 | Novozymes Biopharma Dk A/S | Modified milk growth factor |
| AU689719B2 (en) * | 1995-05-02 | 1998-04-02 | Novozymes Biopharma Dk A/S | Method of preventing or treating alimentary tract damage due to chemotherapy or radiation |
| DE69719190D1 (de) * | 1996-07-02 | 2003-03-27 | Pharmaproducts Uk Ltd | Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung |
| GB9619634D0 (en) * | 1996-09-20 | 1996-11-06 | Scient Hospital Suppl Int Ltd | Prevention of gastrointestinal damage |
| GB9619660D0 (en) * | 1996-09-20 | 1996-11-06 | Scient Hospital Suppl Int Ltd | Prevention of gastrointestinal damage |
| CA2223198A1 (en) * | 1997-01-14 | 1998-07-14 | Societe Des Produits Nestle S.A. | Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract |
| EP0852913A1 (de) * | 1997-01-14 | 1998-07-15 | Societe Des Produits Nestle S.A. | Zusammensetzung und Methode zur Behandlung inflammatorischer Zustände des Magen-Darm-Traktes |
| WO1998031793A2 (en) * | 1997-01-15 | 1998-07-23 | The Rowett Research Institute | Immunomodulating properties, amino acid and nucleotide sequence of colostrum derived growth factor |
| EP0875155A1 (de) * | 1997-05-01 | 1998-11-04 | N.V. Nutricia | Perioperatives Getränk |
| US5965465A (en) * | 1997-09-18 | 1999-10-12 | International Business Machines Corporation | Etching of silicon nitride |
| AUPP031897A0 (en) * | 1997-11-12 | 1997-12-04 | Gropep Pty Ltd | Mammalian milk growth factor |
| FR2827290B1 (fr) | 2001-07-13 | 2004-07-09 | Pierre Jouan Biotechnologies Sa | Procede d'obtention d'une fraction proteique enrichie en tgf-beta sous forme activee, fraction proteique et applications therapeutiques |
| JP2005522986A (ja) * | 2001-10-19 | 2005-08-04 | ジェネンテック・インコーポレーテッド | 炎症性腸疾患の診断と治療のための組成物と方法 |
| WO2003057257A1 (en) * | 2002-01-02 | 2003-07-17 | The Johns Hopkins University | Cc10 inhibits th2 cytokines and eotaxins involved in allergic diseases |
| AU2004219603A1 (en) * | 2003-03-11 | 2004-09-23 | Genentech, Inc. | Novel compositions and methods for the treatment of immune related disease |
| PL1638416T3 (pl) * | 2003-06-23 | 2013-09-30 | Nestec Sa | Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej |
| EP1675480B1 (de) | 2003-10-16 | 2018-06-13 | Nestec S.A. | Nahrhafte zusammensetzung gegen die nebenwirkungen von chemotherapie oder strahlentherapie |
| US7763257B2 (en) | 2004-12-09 | 2010-07-27 | Christina Juneau | Compositions comprising transforming growth factor (TGF)-β1 and TGF-β2 in admixture of proteins obtained from dairy products |
| US20060127493A1 (en) * | 2004-12-09 | 2006-06-15 | Yves Pouliot | Composition for treating psoriasis |
| US7572474B2 (en) | 2005-06-01 | 2009-08-11 | Mead Johnson Nutrition Company | Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants |
| US8287931B2 (en) * | 2005-06-30 | 2012-10-16 | Mead Johnson Nutrition Company | Nutritional composition to promote healthy development and growth |
| US8075934B2 (en) * | 2008-10-24 | 2011-12-13 | Mead Johnson Nutrition Company | Nutritional composition with improved digestibility |
| US7744895B2 (en) | 2005-08-31 | 2010-06-29 | Yamanashi University | Methods of treating allergies using TGF-β1 and allergens |
| JP5167480B2 (ja) * | 2005-08-31 | 2013-03-21 | 国立大学法人山梨大学 | アレルギー予防方法又は治療方法、飲食品、並びに経口医薬品 |
| US20090186034A1 (en) * | 2006-12-19 | 2009-07-23 | Genetech, Inc. | Gene expression markers for inflammatory bowel disease |
| KR20100056515A (ko) | 2007-09-11 | 2010-05-27 | 몬도바이오테크 래보래토리즈 아게 | 치료제로서의 펩티드의 용도 |
| EP2190450A2 (de) | 2007-09-11 | 2010-06-02 | Mondobiotech Laboratories AG | Verwendung von melaninkonzentrierendem hormon und met-enkephalin als therapeutika |
| AU2008310007A1 (en) | 2007-09-11 | 2009-04-16 | Mondobiotech Laboratories Ag | Combination of splenopentin and thymopentin and the use thereof in medicine |
| CA2698980A1 (en) | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
| WO2009033739A2 (en) | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
| RU2010114039A (ru) | 2007-09-11 | 2011-10-20 | Мондобайотек Лабораториз Аг (Li) | Применение октреотида в качестве терапевтического средства |
| WO2009033741A2 (en) | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of lvv-hemorphin-6 and optionally af12198 as therapeutic agent(s) |
| JP2010539057A (ja) | 2007-09-11 | 2010-12-16 | モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト | 治療剤としてのヒト膵臓ポリペプチドの使用 |
| EP2197471A2 (de) | 2007-09-11 | 2010-06-23 | Mondobiotech Laboratories AG | Verwendung der peptide maippkknqdk (cow kappa casein 106-116) und/oder ygfqna (serorphin) als therapeutische mittel |
| WO2009033781A2 (en) | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
| RU2010114038A (ru) | 2007-09-11 | 2011-10-20 | Мондобайотек Лабораториз Аг (Li) | Применение адреномедуллина в качестве терапевтического средства для лечения избыточного ангиогенеза |
| RU2010114018A (ru) | 2007-09-11 | 2011-10-20 | Мондобайотек Лабораториз Аг (Li) | Применение пептид тимозина бета 4 индивидуально или в сочетании с цекропином а в качестве терапевтического средства |
| WO2009033661A2 (en) | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
| JP5395794B2 (ja) | 2007-09-11 | 2014-01-22 | モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト | 治療剤としてのガラニンペプチドの使用 |
| AU2008306131A1 (en) | 2007-09-11 | 2009-04-09 | Mondobiotech Laboratories Ag | Use of band 3 protein and PACAP-27 as a therapeutic agent |
| WO2009033792A2 (en) | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Gamma 1 msh alone or in combination with pentagastrin as a therapeutic agent |
| WO2009046881A1 (en) | 2007-09-11 | 2009-04-16 | Mondobiotech Laboratories Ag | Use of a peptide combination including c-peptide, as a therapeutic agent |
| KR20100071983A (ko) | 2007-09-11 | 2010-06-29 | 몬도바이오테크 래보래토리즈 아게 | 항―ｈｉｖ제로서의 ｒｇｄ－펩티드 및／또는 부갑상선 호르몬（１－３４）의 용도 |
| WO2009033790A2 (en) | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
| WO2009040051A2 (en) | 2007-09-11 | 2009-04-02 | Mondobiotech Laboratories Ag | Use of the peptide rfmwmk alone or in combination with the peptide ymdgtmsqv as a therapeutic agent |
| CA2698682A1 (en) | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
| US20090072409A1 (en) * | 2007-09-14 | 2009-03-19 | International Business Machines Corporation | Interconnect Structures Incorporating Air-Gap Spacers |
| US20090075470A1 (en) * | 2007-09-14 | 2009-03-19 | International Business Machines Corporation | Method for Manufacturing Interconnect Structures Incorporating Air-Gap Spacers |
| AU2008334095A1 (en) | 2007-11-29 | 2009-06-11 | Genentech, Inc. | Gene expression markers for inflammatory bowel disease |
| JP2012501977A (ja) | 2008-09-09 | 2012-01-26 | モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト | 治療剤としてのペプチドの使用 |
| US8367354B2 (en) | 2008-10-24 | 2013-02-05 | Mead Johnson Nutrition Company | Methods for determining the levels of TGF-β in a composition |
| US8986769B2 (en) | 2008-10-24 | 2015-03-24 | Mead Johnson Nutrition Company | Methods for preserving endogenous TGF-β |
| US8350006B2 (en) | 2008-10-24 | 2013-01-08 | Mead Johnson Nutrition Company | Methods for determining the bioactivity of TGF-β in a composition |
| US8293264B2 (en) * | 2009-05-11 | 2012-10-23 | Mead Johnson Nutrition Company | Nutritional composition to promote healthy development and growth |
| AU2010276392A1 (en) | 2009-07-20 | 2012-03-08 | Genentech, Inc. | Gene expression markers for Crohn's disease |
| US9066526B2 (en) * | 2009-10-16 | 2015-06-30 | Dairy Australia Limited | Allergy treatment using acid treated aqueous whey protein extract |
| WO2012071436A1 (en) | 2010-11-24 | 2012-05-31 | Genentech, Inc. | Method of treating autoimmune inflammatory disorders using il-23r loss-of-function mutants |
| JP5890100B2 (ja) | 2011-02-09 | 2016-03-22 | 雪印メグミルク株式会社 | 皮膚コラーゲン産生促進剤 |
| BR112015001884B1 (pt) * | 2012-07-31 | 2020-12-01 | Société des Produits Nestlé S.A. | composição nutricional para promover a saúde musculoesquelética em pacientes com doença inflamatória intestinal (ibd), seu uso, e formulação farmacêutica, formulação nutricional, formulação de alimentação por tubo, suplemento alimentar, alimento funcional ou produto de bebida |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4440860A (en) * | 1980-01-18 | 1984-04-03 | The Children's Medical Center Corporation | Stimulating cell growth |
| EP0269408A3 (de) * | 1986-11-26 | 1989-08-30 | Genentech, Inc. | TGF-Beta für die Behandlung von entzündlichen Erkrankungen |
| US4977137B1 (en) * | 1987-06-03 | 1994-06-28 | Baylor College Medicine | Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract |
| GB8723094D0 (en) * | 1987-10-01 | 1987-11-04 | Ciba Geigy Ag | Polypeptide growth factor from milk |
| WO1990000900A1 (en) * | 1988-07-20 | 1990-02-08 | Amgen Inc. | Method of treating inflammatory disorders by reducing phagocyte activation |
| US5135915A (en) * | 1988-10-14 | 1992-08-04 | Genentech, Inc. | Method for the treatment of grafts prior to transplantation using TGF-.beta. |
-
1991
- 1991-08-12 ES ES91810629T patent/ES2110986T3/es not_active Expired - Lifetime
- 1991-08-12 DE DE69128283T patent/DE69128283T2/de not_active Expired - Lifetime
- 1991-08-12 EP EP91810629A patent/EP0527283B1/de not_active Expired - Lifetime
- 1991-08-12 AT AT91810629T patent/ATE160486T1/de not_active IP Right Cessation
- 1991-08-12 DK DK91810629T patent/DK0527283T3/da active
-
1992
- 1992-07-07 AU AU19521/92A patent/AU658900B2/en not_active Ceased
- 1992-08-11 BR BR929203106A patent/BR9203106A/pt not_active Application Discontinuation
- 1992-08-11 JP JP4213998A patent/JP2784297B2/ja not_active Expired - Fee Related
- 1992-08-11 PT PT100766A patent/PT100766B/pt not_active IP Right Cessation
- 1992-08-12 KR KR1019920014522A patent/KR930003844A/ko not_active Application Discontinuation
-
1995
- 1995-02-21 US US08/391,634 patent/US5461033A/en not_active Expired - Lifetime
-
1997
- 1997-12-10 GR GR970403299T patent/GR3025647T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2784297B2 (ja) | 1998-08-06 |
| DE69128283T2 (de) | 1998-03-19 |
| EP0527283A1 (de) | 1993-02-17 |
| KR930003844A (ko) | 1993-03-22 |
| JPH05284936A (ja) | 1993-11-02 |
| DE69128283D1 (de) | 1998-01-08 |
| AU1952192A (en) | 1993-02-18 |
| EP0527283B1 (de) | 1997-11-26 |
| DK0527283T3 (da) | 1998-08-10 |
| BR9203106A (pt) | 1993-03-30 |
| GR3025647T3 (en) | 1998-03-31 |
| PT100766B (pt) | 1999-10-29 |
| US5461033A (en) | 1995-10-24 |
| ES2110986T3 (es) | 1998-03-01 |
| AU658900B2 (en) | 1995-05-04 |
| PT100766A (pt) | 1993-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69128283D1 (de) | Nahrungsmittelzusammensetzung | |
| FI864559A0 (fi) | Nya insulinderivat och farmaceutiska preparat innehaollande dessa derivat. | |
| IL101348A0 (en) | Polyethylene glycol protein conjugates,their preparation and pharmaceutical compositions containing them | |
| ATE197053T1 (de) | Humaner rezeptor fc(gamma)riii | |
| NO932867L (no) | Vandige dispersjoner av zein og faste preparater med regulert frigjoerelse og med belegg avledet fra dispersjonene | |
| ATE151278T1 (de) | Pharmazeutische und dermokosmetische mittel enthaltend pferdecolostrum | |
| DK88385D0 (da) | Biologisk nedbrydeligt polypeptid samt anvendelse deraf til gradvis frigivelse af laegemidler | |
| ES2103987T3 (es) | Usos de acidos grasos alfa-hidroxilados. | |
| GR3032543T3 (en) | Signal transmission and tag power consumption measurement circuit for an inductive reader. | |
| DK398683D0 (da) | Fremgangsmade til fremstilling af antistoffer | |
| DK0588177T3 (da) | Interferon-alpha/beta-bindende protein, fremstilling heraf samt farmaceutiske præparater indeholdende proteinet | |
| DK0714910T3 (da) | Anvendelse af et decapeptid med aktivitet af benzodiazepintype til fremstilling af medikamenter og kosttilskud | |
| OA09794A (fr) | Dérivés de pyridone amino acide azetidinyl substitués, leur préparation et leur application en tant que médicaments. | |
| AU666482B2 (en) | Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use | |
| DE69833568D1 (de) | Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe | |
| IT1264637B1 (it) | Composizioni farmaceutiche e/o dermocosmetologiche e cosmetiche contenenti colostro equino | |
| IT1053845B (it) | Procedimento per l arricchimento di prodotti agricoli in proteine e vitamine | |
| ATE252325T1 (de) | Antioxidative zusammensetzungen mit süssmolkekonzentrat und casein | |
| IT1265252B1 (it) | Composizioni farmaceutiche e/o dermocosmetologiche e cosmetiche contenenti colostro bovino. | |
| ITMI930118A0 (it) | Composizioni farmaceutiche e/o dermocosmetologiche e cosmetiche contenenti colostro o latte di equino |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |